Brainstorm Cell Therapeutics Inc (BCLI) insider trading
Every open-market stock purchase and sale by Brainstorm Cell Therapeutics Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- No open-market insider trades in the last 12 months.
- Last insider buy: Chaim Lebovits (CEO), $6.3K, 2 years ago.
Last 12 months: insiders bought $0 (0 buys) and sold $0 (0 sales). Last close $1.17 on Jul 17, 2025.
Recent BCLI insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Jul 24, 2026 | Peter Joe Pitts (Chair) | Bought (not open market) | — |
| Jul 24, 2026 | Jacob A Frenkel (Director) | Bought (not open market) | — |
| Feb 26, 2026 | Hartoun Hartounian (Director) | Bought (not open market) | $158K |
| Feb 26, 2026 | Ibrahim B. Dagher (Director) | Bought (not open market) | $158K |
| Feb 26, 2026 | Nir Naor (Director) | Bought (not open market) | $126K |
| Feb 26, 2026 | Stacy Lindborg (Director) | Bought (not open market) | $105K |
| Feb 26, 2026 | Anthony J. Polverino (Director) | Bought (not open market) | $105K |
| Feb 26, 2026 | Menghisteab Bairu (Director) | Bought (not open market) | $105K |
| Feb 26, 2026 | Jacob A Frenkel (Director) | Bought (not open market) | — |
| Feb 26, 2026 | Alla Patlis (Officer) | Bought (not open market) | — |
| Feb 26, 2026 | Uri Yablonka (C-suite exec) | Bought (not open market) | — |
| Feb 26, 2026 | Chaim Lebovits (CEO) | Bought (not open market) | — |
| Feb 26, 2026 | Irit Arbel (Director) | Bought (not open market) | — |
Who's trading BCLI
- Jacob A Frenkel, Director: other filings, last Jul 24, 2026
- Peter Joe Pitts, Chair: other filings, last Jul 24, 2026
- Ibrahim B. Dagher, C-suite exec: other filings, last Feb 26, 2026
- Hartoun Hartounian, COO: other filings, last Feb 26, 2026
- Chaim Lebovits, CEO: other filings, last Feb 26, 2026
- Stacy Lindborg, Director: other filings, last Feb 26, 2026
- Nir Naor, Director: other filings, last Feb 26, 2026
- Alla Patlis, Officer: other filings, last Feb 26, 2026
- Anthony J. Polverino, Director: other filings, last Feb 26, 2026
- Irit Arbel, Director: other filings, last Feb 26, 2026
- Uri Yablonka, C-suite exec: other filings, last Feb 26, 2026
- Menghisteab Bairu, Director: other filings, last Feb 26, 2026
Get free alerts when an insider at Brainstorm Cell Therapeutics Inc files a new trade →